Impedance-based cellular assay technologies: recent advances, future promise

Current Opinion in Pharmacology

Volumn 7, Issue 5, 2007, Pages 535-540

  McGuinness, Ryan ^a  

^a MOLECULAR DEVICES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

AUTOANALYZER; AUTOMATION; BIOTECHNOLOGY; CARCINOMA CELL; CELL ASSAY; CELL DEATH; CELL INTERACTION; CELL PROLIFERATION; CYTOTOXICITY; DIMERIZATION; DRUG RESEARCH; DRUG SCREENING; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; FREQUENCY MODULATION; HUMAN; IMPEDANCE; MEDICAL TECHNOLOGY; MONOLAYER CULTURE; OLIGOMERIZATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSTATE CARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TARGET CELL;

BIOLOGICAL ASSAY; ELECTRIC IMPEDANCE; HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 35248895259     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.08.004     Document Type: Review

References (31)

1. Overington J.P., Al-Lazikani B., and Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 5 (2006) 993-996
2. Paolini G.V., Shapland R.H., van Hoorn W.P., Mason J.S., and Hopkins A.L. Global mapping of pharmacological space. Nat Biotechnol 24 (2006) 805-815
3. Kortagere S., and Welsh W.J. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors. J Comput Aided Mol Des 20 (2006) 789-802
4. Leach A.R., Hann M.M., Burrows J.N., and Griffen E.J. Fragment screening: an introduction. Mol Biosyst 2 (2006) 430-446
5. Jacoby E., Bouhelal R., Gerspacher M., and Seuwen K. The 7 TM G-protein-coupled receptor target family. Chem Med Chem 1 (2006) 761-782. Authors provide a comprehensive review of the history and state of the art in GPCR biology and screening. Current approaches to creation of combinatorial libraries and screening strategies are discussed. Authors also consider how recent advances will affect future discoveries.
6. Grimnes S., and Martinsen O.G. Bioimpedance and Bioelectricity Basics (2000), Academic Press
7. Foster K.R., and Schwan H.P. Dielectric properties of tissues and biological materials: a critical review. Crit Rev Biomed Eng 17 (1989) 25-104
8. Leung G.T.H., McGuinness R., Verdonk E., Michelotti J.M., and Liu V.F. Cellular dielectric spectroscopy: a label free technology for drug discovery. J Assoc Lab Autom (JALA) 10 (2005) 258-269. Authors describe cellular dielectric spectroscopy from a basic physics and cell biological viewpoint. They discuss unique response profiles generated when analyzing different classes of GPCR's and PTKR's, and demonstrate their utility in drug discovery applications.
9. Giaever I., and Keese C.R. A morphological biosensor for mammalian cells. Nature 366 (1993) 591-592
10. Atienza J.M., Yu N., Kirstein S.L., Xi B., Wang X., Xu X., and Abassi Y.A. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol 4 (2006) 597-607
11. Verdonk E., Johnson K., McGuinness R., Leung G., Chen Y.W., Tang H.R., Michelotti J.M., and Liu V.F. Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 4 (2006) 609-619. Investigating a panel of well-known cell lines, the authors identify many important endogenously expressed GPCR and PTKR receptor targets. This represents one of the first attempts to catalog active endogenous receptors on cell lines using impedance technology.
12. Peters M.F., Knappenberger K.S., Wilkins D., Sygowski L.A., Lazor L.A., Liu J., and Scott C.W. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 12 (2007) 312-319. Focusing on difficult Gαi-coupled GPCR targets, the authors validated several CellKey™ system assays. Comparative data is shown, and the advantages of using a label-free assay which is sensitive to endogenous receptor activation are discussed.
13. Sanchez-Laorden B.L., Sanchez-Mas J., Martinez-Alonso E., Martinez-Menarguez J.A., Garcia-Borron J.C., and Jimenez-Cervantes C. Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J Invest Dermatol 126 (2006) 172-181
14. Daniels D.J., Kulkarni A., Xie Z., Bhushan R.G., and Portoghese P.S. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. J Med Chem 48 (2005) 1713-1716
15. D'Ambrosi N., Iafrate M., Saba E., Rosa P., and Volonte C. Comparative analysis of P2Y(4) and P2Y(6) receptor architecture in native and transfected neuronal systems. Biochim Biophys Acta 1768 (2007) 1592-1599
16. Gesty-Palmer D., Chen M., Reiter E., Ahn S., Nelson C.D., Wang S., Eckhardt A.E., Cowan C.L., Spurney R.F., Luttrell L.M., et al. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281 (2006) 10856-10864
17. Goldbard S. Bringing primary cells to mainstream drug development and drug testing. Curr Opin Drug Discov Dev 9 (2006) 110-116
18. Gheorghiu E., Balut C., and Gheorghiu M. Dielectric behaviour of gap junction connected cells: a microscopic approach. Phys Med Biol 47 (2002) 341-348
19. Glamann J., and Hansen A.J. Dynamic detection of natural killer cell-mediated cytotoxicity and cell adhesion by electrical impedance measurements. Assay Drug Dev Technol 4 (2006) 555-563
20. Xing J.Z., Zhu L., Gabos S., and Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro 20 (2006) 995-1004
21. Hartmann C., Zozulya A., Wegener J., and Galla H.J. The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. Exp Cell Res 313 (2007) 1318-1325
22. Saxena N.K., Sharma D., Ding X., Lin S., Marra F., Merlin D., and Anania F.A. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67 (2007) 2497-2507
23. Moy A.B., Winter M., Kamath A., Blackwell K., Reyes G., Giaever I., Keese C., and Shasby D.M. Histamine alters endothelial barrier function at cell-cell and cell-matrix sites. Am J Physiol Lung Cell Mol Physiol 278 (2000) L888-L898
24. Street M., Marsh S.J., Stabach P.R., Morrow J.S., Brown D.A., and Buckley N.J. Stimulation of Galphaq-coupled M1 muscarinic receptor causes reversible spectrin redistribution mediated by PLC, PKC and ROCK. J Cell Sci 119 (2006) 1528-1536
25. Volovyk Z.M., Wolf M.J., Prasad S.V., and Rockman H.A. Agonist-stimulated beta-adrenergic receptor internalization requires dynamic cytoskeletal actin turnover. J Biol Chem 281 (2006) 9773-9780
26. Ciambrone G.J., Liu V.F., Lin D.C., McGuinness R.P., Leung G.K., and Pitchford S. Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis. J Biomol Screen 9 (2004) 467-480
27. Tate A., Isotani S., Bradley M.J., Sikes R.A., Davis R., Chung L.W., and Edlund M. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 6 (2006) 197
28. Cornelio D., Roesler R., and Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol (2007)
29. Panigone S., and Nunn A.D. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy. Q J Nucl Med Mol Imaging 50 (2006) 310-321
30. Harikumar K.G., Morfis M.M., Lisenbee C.S., Sexton P.M., and Miller L.J. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Mol Pharmacol 69 (2006) 363-373
31. Pin J.P., Neubig R., Bouvier M., Devi L., Filizola M., Javitch J.A., Lohse M.J., Milligan G., Palczewski K., Parmentier M., et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 59 (2007) 5-13